Gene Therapy

I think we've got to the point, you know, if you look at the success with the personalized mRNA vaccine, plus a PD-1 inhibitor, that's going to have to believe generate a lot of interest. I think in cell therapy where over the last few years, there's been the lament that we're restricted to hematologic malignancies and maybe narrow indications, we're starting to see some progress in targeting solid tumors. We're now starting to see that cell therapy move into autoimmune disease with the CAR-T-REGs as an example. There are some areas that have been out of favor but could come back in favor. Immuno oncology has been out